In the subgroup of HCC patients with tumors ≥ 5 cm, high POU2F1 expression showed apparent prognostic value for predicting poorer OS and higher death rates (P = 0.0488) (Figure 3C and 3D). This evidence concerns the gene POU2F1 and hepatocellular carcinoma.